Skip to content

Impact of Open Label Placebo Administration on Cognition and Well-being

Impact of Open Label Placebo Administration on Cognition and Well-being - OLP KOBEF

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00013557
Enrollment
165
Registered
2017-12-20
Start date
2017-12-21
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

Sponsors

Universitätsklinikum EssenKlinik für Neurologie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age> 18 years, successfully completed registration for the first attempt of the examination of the first section of Medicine (M1) or a comparable examination of another study section or course, Volunteers, informed consent to study participation

Exclusion criteria

Exclusion criteria: Severe medical conditions (in particular, diagnosed psychiatric comorbidities, in particular harmful substance abuse (including alcohol, cannabinoids, cocaine, amphetamines) in the last 4 weeks prior to inclusion or persistence; Known allergy or intolerance to any of the ingredients of the placebo; Parallel participation in a study using investigational medicinal products.

Design outcomes

Primary

MeasureTime frame
The primary outcome variable is the documented examination performance in a standardized, regional, written multiple-choice exam (end term exam (ZAK), M1 (Medicine)) and is measured as the proportion of correctly solved tasks in all completed tasks.

Secondary

MeasureTime frame
Secondary outcome variable is well-being before the exam and while preparing for the exam compared to scores of standardized questionnaires (PSQ20 (stress), ADS-K (depression), PSQI (sleep quality), SOMS (somatization), STAI-G-X1 (anxiety).

Countries

Germany

Contacts

Public ContactJulian Kleine-Borgmann

Universitätsklinikum EssenKlinik für Neurologie

julian.kleine-borgmann@uk-essen.de00492017232439

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 24, 2026